In This Issue
Taking Aim at ALK Across the Blood–Brain Barrier
Role of Selected Genetic Variants in Lung Cancer Risk in African Americans
Pathobiological Implications of MUC4 in Non–Small-Cell Lung Cancer
Patterns of DNA Mutations and ALK Rearrangement in Resected Node Negative Lung Adenocarcinoma
Heterogeneity of Genetic Changes Associated with Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancer
A Phase I Study of Pomalidomide (CC-4047) in Combination with Cisplatin and Etoposide in Patients with Extensive-Stage Small-Cell Lung Cancer
The Prognostic Value of Ratio-Based Lymph Node Staging in Resected Non–Small-Cell Lung Cancer
Feasibility of Image-Guided Transthoracic Core-Needle Biopsy in the BATTLE Lung Trial
A Retrospective Analysis of VeriStrat Status on Outcome of a Randomized Phase II Trial of First-Line Therapy with Gemcitabine, Erlotinib, or the Combination in Elderly Patients (Age 70 Years or Older) with Stage IIIB/IV Non–Small-Cell Lung Cancer
Noninvasive Characterization of the Histopathologic Features of Pulmonary Nodules of the Lung Adenocarcinoma Spectrum using Computer-Aided Nodule Assessment and Risk Yield (CANARY)—A Pilot Study
Correlation of Mutation Status and Survival with Predominant Histologic Subtype According to the New IASLC/ATS/ERS Lung Adenocarcinoma Classification in Stage III (N2) Patients
Thymidylate Synthase and Folyl-Polyglutamate Synthase Are Not Clinically Useful Markers of Response to Pemetrexed in Patients with Malignant Pleural Mesothelioma
Lung Volume Measurements as a Surrogate Marker for Patient Response in Malignant Pleural Mesothelioma
Trimodality Therapy for Stage II–III Carcinoma of the Esophagus
Prognostic Factors and Outcome for Patients with Esophageal Squamous Cell Carcinoma Underwent Surgical Resection Alone
FDG PET-CT Aids in the Preoperative Assessment of Patients with Newly Diagnosed Thymic Epithelial Malignancies
“Pseudocavitation” in Thymic Carcinoma During Treatment with Sunitinib
Ineffectiveness of Crizotinib on Brain Metastases in Two Cases of Lung Adenocarcinoma with EML4-ALK Rearrangement
Rapid Response of Brain Metastasis to Crizotinib in a Patient with ALK Rearrangement–Positive Non–Small-Cell Lung Cancer
Chronic Obstructive Pulmonary Disease and Risk of Lung Cancer
Chronic Obstructive Pulmonary Disease and Risk of Lung Cancer
Balancing Radiation Pneumonitis Versus Locoregional Tumor Control in Non–Small-Cell Lung Cancer
Two Rare Exon 21 EGFR Mutations in Patients Treated with Gefitinib